Answers are grounded in this paper and cite their sources.
Regulatory update reports the approval of Rextovy over-the-counter naloxone nasal spray for opioid overdose, highlighting expanded public access to emergency reversal treatments.
The FDA has approved the over-the-counter (OTC) sale of Rextovy (Amphastar), a nasal spray formulation of the opioid antagonist naloxone, for emergency treatment of opioid overdose.1 Other naloxone nasal sprays (Narcan, and generics; RiVive) are also available OTC (see Table 1).
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: